Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

261.05 +2.30 (+0.89%)
Streaming Delayed Price Updated: 2:12 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 345,131
Open 256.68
Bid (Size) 260.40 (5)
Ask (Size) 261.07 (2)
Prev. Close 258.75
Today's Range 255.75 - 261.12
52wk Range 160.19 - 289.46
Shares Outstanding 68,873,869
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Reasons Investors Love Insulet (PODD)
Over the past six months, Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This was partly due to its solid quarterly results, and... 
Via StockStory
Topics Stocks
Exposures US Equities
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
Via Benzinga

Performance

YTD
+1.6%
+1.6%
1 Month
-4.1%
-4.1%
3 Month
-0.9%
-0.9%
6 Month
+12.2%
+12.2%
1 Year
+55.3%
+55.3%

More News

Read More
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections
From Insulet Corporation
Via Business Wire
What's Driving the Market Sentiment Around Insulet?
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Insulet Announces Pricing of Senior Notes Due 2033
From Insulet Corporation
Via Business Wire
Insulet Announces Proposed Financing Transactions
From Insulet Corporation
Via Business Wire
Insulet Expands Omnipod® 5 to Four More International Markets
From Insulet Corporation
Via Business Wire
Assessing Insulet: Insights From 6 Financial Analysts
Via Benzinga
From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes
From Insulet Corporation
Via Business Wire
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Insulet to Host Investor Day on June 5, 2025
From Insulet Corporation
Via Business Wire
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exploring the Growth Potential of INSULET CORP (NASDAQ:PODD) as It Nears a Breakout.
Via Chartmill
1 Mid-Cap Stock on Our Watchlist and 2 to Ignore
Via StockStory
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Which S&P500 stocks are moving on Tuesday?
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
These S&P500 stocks are gapping in today's session
Via Chartmill
Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow
Via StockStory
Integra LifeSciences (IART) Reports Earnings Tomorrow: What To Expect
Via StockStory
Curious about which S&P500 stocks are generating unusual volume on Friday? Find out below.
Via Chartmill
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst
Via Benzinga
These S&P500 stocks are moving in today's pre-market session
Via Chartmill

Frequently Asked Questions

Is Insulet Corporation - Common Stock publicly traded?
Yes, Insulet Corporation - Common Stock is publicly traded.
What exchange does Insulet Corporation - Common Stock trade on?
Insulet Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insulet Corporation - Common Stock?
The ticker symbol for Insulet Corporation - Common Stock is PODD on the Nasdaq Stock Market
What is the current price of Insulet Corporation - Common Stock?
The current price of Insulet Corporation - Common Stock is 261.05
When was Insulet Corporation - Common Stock last traded?
The last trade of Insulet Corporation - Common Stock was at 03/31/25 02:12 PM ET
What is the market capitalization of Insulet Corporation - Common Stock?
The market capitalization of Insulet Corporation - Common Stock is 17.98B
How many shares of Insulet Corporation - Common Stock are outstanding?
Insulet Corporation - Common Stock has 18B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.